Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
HIV Infections
Interventions
DRUG

Kivexa

abacavir 600mg + lamivudine 300mg in one tablet QD

Trial Locations (20)

15405

Hospital Arquitecto Marcide, Ferrol

15706

Hospital Clínico Universitario de Santiago, Santiago de Compostela

18014

Hospital Virgen de las Nieves, Granada

25125

Institute of Infections and Tropical Diseases University of Brescia, Brescia

28007

Hopsital Gregorio Marañón, Madrid

28041

Hospital 12 de Octubre, Madrid

29600

Hopsital Costa del Sol, Marbella

30003

Hospital General de Murcia, Murcia

30203

Hospital Nuestra Sra del Rosell, Cartagena

33006

Hospital Central de Asturias, Asturias

36204

Hospital Xeral de Vigo, Vigo

38320

Hospital Universitario de Canarias, Santa Cruz de Tenerife

41009

Hospital Virgen Macarena, Seville

41013

Hospital Virgen del Rocío, Seville

43007

Hospital de Tarragona, Tarragona

46017

Hospital Universitari Dr. Peset, Valencia

50009

Hospital Miguel Servet, Zaragoza

03010

Hospital Generall de Alicante, Alicante

08916

Hospital Universitari Germans Trias i Pujol, Badalona

08400

Hospital de Granollers, Granollers

All Listed Sponsors
collaborator

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

OTHER

lead

Germans Trias i Pujol Hospital

OTHER

NCT00318123 - Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients | Biotech Hunter | Biotech Hunter